Le Lézard
Classified in: Health, Science and technology, Business
Subject: IMA

Akeso Received Payment for the Development Collaboration on Tagitanlimab


HONG KONG, Jan. 22, 2025 /PRNewswire/ -- On January 22, 2025, Akeso Inc. (9926.HK) announced that it had received payment from Sichuan Kelun Pharmaceutical Research Institute Co., Ltd. ("Sichuan Kelun") for their collaboration on the development of tagitanlimab, an innovative humanized monoclonal antibody targeting PD-L1, following its recent marketing approval by China's National Medical Products Administration.

In 2014, Akeso signed a cooperation agreement with Sichuan Kelun for the development of tagitanlimab. Under the terms of the agreement, Akeso will receive royalties from the commercial sales of tagitanlimab in addition to the development payment.

Tagitanlimab marks Akeso's second oncology product to yield commercial royalties, following pucotenlimab, a PD-1 monoclonal antibody developed in collaboration with Lepu Biopharma in 2016.

Dr. Yu Xia, founder, chairwoman, president, and CEO of Akeso, said: "Congratulations to our partners. We are thrilled about continuously successful approval of our innovative products, and truly anticipate their outstanding commercialization performance. This achievement highlights Akeso's strong R&D capabilities and our commitment to innovation. Since its inception, Akeso has established multiple external collaborations, including ivonescimab with Summit Therapeutics, quavonlimab with Merck and pucotenlimab with Lepu Biopharma. These partnerships not only benefit patients but also deliver significant returns for both Akeso and our collaborators. Looking ahead, Akeso will continue to pursue a diversified strategy for new drug development, leveraging global resources to drive the high-quality commercialization of our independently developed innovative therapeutics."

SOURCE Akeso, Inc.


These press releases may also interest you

at 04:05
Vantage Markets is proud to announce its success at the 5th Annual Business Tabloid Awards, held on 23rd January 2025 in Dubai. The Annual Business Tabloid Awards celebrate outstanding achievements across industries, including banking, finance,...

14 fév 2025
Report on how AI is driving market transformation - The global fast fashion market size is estimated to grow by USD 79.2 billion from 2025-2029, according to Technavio. The market is estimated to grow at a CAGR of 11% during the forecast period....

14 fév 2025
Report on how AI is redefining market landscape - The global smartwatch market  size is estimated to grow by USD 46.3 billion from 2025-2029, according to Technavio. The market is estimated to grow at a CAGR of  15.5%  during the forecast period....

14 fév 2025
Report with the AI impact on market trends - The global mobile application market size is estimated to grow by USD 2.63 trillion from 2025-2029, according to Technavio. The market is estimated to grow at a CAGR of 31.1% during the forecast period....

14 fév 2025
Report with market evolution powered by AI - The global cryptocurrency market size is estimated to grow by USD 39.75 billion from 2025-2029, according to Technavio. The market is estimated to grow at a CAGR of  16.7%  during the forecast period....

14 fév 2025
Report on how AI is redefining market landscape - The global carbon accounting software market  size is estimated to grow by USD 33.08 billion from 2025-2029, according to Technavio. The market is estimated to grow at a CAGR of  38.5%  during the...



News published on and distributed by: